Skip to main content
TVTX
NASDAQ Life Sciences

FILSPARI Sales Jump 120% to $200M as Travere Posts Q3 Results

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$49.26
Mkt Cap
$4.643B
52W Low
$22.59
52W High
$68.73
52W Position info
118% above low
Off High info
28% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

TVTX has more than doubled off its 52-week low of $22.59.

Summary

FILSPARI net product sales hit $200.2 million in Q3 2026, up 120% year-over-year, driving total net product sales to $220.2 million from $113.2 million a year earlier. That is a sharp acceleration from the $141.1 million reported in Q2, and the FSGS launch is contributing with 1,932 new patient start forms in the quarter. The quarter still showed a GAAP net loss of $52.3 million, or $0.55 per share, largely because of a $113.1 million IPR&D charge tied to closing the Everest Medicines civorebrutinib licensing deal; on a non-GAAP basis the loss was $29.6 million, or $0.31 per share. Cash and marketable securities stood at $471.8 million at quarter-end, with convertible debt of $603.5 million on the balance sheet. The commercial trajectory is the story here, and it lands just ahead of the December 1 CEO handoff to Bradley Campbell. Pegtibatinase Phase 3 HARMONY topline data is guided for the second half of 2027.

At the time of this announcement, TVTX was trading at $49.26 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.6B. The 52-week trading range was $22.59 to $68.73. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

TVTX - Latest Insights

TVTX
Oct 02, 2026, 10:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $56.55
Real-time Price: $51.10 info
Change: -$5.45 (-10%) info
Market Cap: $4.905B info
TVTX
Sep 21, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $62.63
Real-time Price: $51.10 info
Change: -$11.53 (-18%) info
Market Cap: $4.905B info
TVTX
Aug 04, 2026, 4:45 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $63.55
Real-time Price: $51.10 info
Change: -$12.45 (-20%) info
Market Cap: $4.905B info
TVTX
Aug 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $62.00
Real-time Price: $51.10 info
Change: -$10.90 (-18%) info
Market Cap: $4.905B info
TVTX
Jun 03, 2026, 11:36 PM EDT
Source: Asian Corporate Newswire
Importance Score:
9
Price at Filing: $45.20
Real-time Price: $51.10 info
Change: +$5.90 (+13%) info
Market Cap: $4.905B info